Cannabigerol Gummies for Recovery After Bladder Removal Surgery for Bladder Cancer
Tests cannabigerol gummies around surgery in adults having bladder cancer removed.
Key facts
- Who runs it
- Stanford University
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Registry title
- The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
- Status
- Not yet recruiting
- Phase
- Early phase 1
- People taking part
- 20 people, planned
- Starts
- Jul 2027
- Expected to end
- May 2028
- Type of study
- Interventional
- Treatments tested
- Cannabigerol
- Record updated
- 23 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in California with non-metastatic bladder cancer who are about to have radical cystectomy with urinary diversion. They will take cannabigerol gummies around the time of surgery.
- Age
- 18 years or older
- Sex
- Men and women can join
- Disease stage
- Non-metastatic bladder cancer, scheduled for radical cystectomy and urinary diversion
- Earlier treatment
- No CBD, cannabigerol or THC use in the last 30 days
Main reasons for not taking part
- History of substance abuse
- History of psychosis or schizophrenia
- CBD, cannabigerol or THC use in the last 30 days
- Pregnant or breastfeeding
- Heart attack or acute coronary syndrome in the 90 days before surgery
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- 18 years of age or older
- Non-metastatic bladder cancer scheduled to undergo radical cystectomy and urinary diversion
- Patient is able to understand consent and is willing and able to provide written informed consent
- Patient makes their own medical decisions
- Lives in state of California
- Patient is able and willing to refrain from using any non-study cannabis during the screening and treatment phases of the study
- Females of childbearing potential to utilize an acceptable birth control method while consuming the gelatin-based chewable medication
- Be able to read and understand the study questionnaires
- Patient agrees to not to operate heavy machinery or engage in activities that require mental alertness while taking the gelatin-based chewable cannabigerol medication, as these substances may cause drowsiness
Who cannot take part
- Patients who have had heart attack or acute coronary syndrome in the 90 days prior to surgery
- History of substance abuse
- History of psychosis or schizophrenia
- CBD or Cannabigerol usage in the last 30 days
- THC usage in the last 30 days
- Pregnant or breastfeeding individuals
Where in United States
- Stanford UniversityPalo Alto, United StatesContact: Jay ShahNot yet recruiting
About the trial
What the trial wants to find out
This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).
The group in the trial
- Cannabigerol GummiesTreatment being tested
Participants will receive cannabigerol gummies (oral, gelatin-based chewable formulation), 25 milligrams per gummy. Dosing will begin approximately 2 weeks prior to cystectomy with urinary diversion at 12.5 milligrams (one-half gummy) three times daily after meals. Based on tolerability, the dose may be increased to 25 milligrams (one gummy) three times daily or reduced to 6.25 milligrams (one-quarter gummy) 1 to 3 times daily. Treatment will continue through the perioperative period and up to 30 days postoperatively.
Treatment: Cannabigerol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
- Plain-language title
- Cannabigerol Gummies for Recovery After Bladder Removal Surgery for Bladder CancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 23 July 2026